Optibrinz T Eye Drop contains Brinzolamide 1% w/v + Timolol 0.5% w/v, a clinically proven anti-glaucoma combination formulated to lower elevated intraocular pressure in patients suffering from open-angle glaucoma and ocular hypertension. Its balanced formulation ensures effective and sustained pressure reduction.
The eye drop works through a dual mechanism of action, where Brinzolamide reduces aqueous humor production by inhibiting carbonic anhydrase, while Timolol further decreases aqueous formation via beta-blockade, providing enhanced IOP control and optic nerve protection.
From a commercial standpoint, Optibrinz T Eye Drop is a high-prescription ophthalmic product, widely used in eye hospitals, glaucoma clinics, and specialty ophthalmology practices, ensuring consistent demand, repeat prescriptions, and stable turnover.
Including Optibrinz T Eye Drop in your portfolio strengthens the anti-glaucoma combination segment, delivering long-term business growth, strong doctor confidence, and competitive advantage for PCD pharma franchise partners.
Common side effects may include mild burning or stinging sensation, blurred vision, bitter taste, eye discomfort, or dryness. Rarely, systemic effects such as fatigue, dizziness, slow heart rate, or breathing difficulty may occur due to Timolol.
Optibrinz T Eye Drop is indicated for the treatment of open-angle glaucoma and ocular hypertension in patients who require combination therapy to achieve adequate intraocular pressure reduction. Use should be under the supervision of an ophthalmologist.
Use Optibrinz T Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Use with caution in patients with respiratory disorders, cardiac conditions, or sulfonamide allergy. Seek medical advice immediately if severe eye irritation, breathing difficulty, or vision changes occur.
Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.